Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
AMG 133 (maridebart cafraglutide) is a bispecific molecule engineered by conjugating a fully human monoclonal anti-human GIPR antagonist antibody to two GLP-1 analogue agonist peptides using amino acid linkers
Research suggests this dual action creates cellular conditions that favor energy expenditure over energy storage, giving researchers a tool to study metabolic switching mechanisms
Peptide research demands reproducibility
Does monosodium glutamate really cause headache
Copyright 2026 by the American Physiological Society
In: Wondrak GT (ed) Skin stress response pathways: environmental factors and molecular opportunities, Springer, Cham, pp 281300
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
